Skip to main content

Gadodiamide Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on Oct 20, 2022.

Gadodiamide is also known as: Omniscan

Gadodiamide Pregnancy Warnings

Gadodiamide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadodiamide is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Gadodiamide Breastfeeding Warnings

There are no data on the excretion of gadodiamide into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadodiamide to nursing women.

See references

References for pregnancy information

  1. "Product Information. Omniscan (gadodiamide)." Novation (2004):

References for breastfeeding information

  1. "Product Information. Omniscan (gadodiamide)." Novation (2004):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.